Results 251 to 260 of about 162,472 (321)

Dual ET<sub>A</sub>-ET<sub>B</sub> receptor antagonism improves metabolic syndrome-induced heart failure with preserved ejection fraction. [PDF]

open access: yesFundam Clin Pharmacol
Lockwood F   +11 more
europepmc   +1 more source

Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy

open access: hybrid, 1990
H E Shubeita   +6 more
openalex   +1 more source

Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential

open access: yesObesity Reviews, Volume 26, Issue 7, July 2025.
Summary With the evolving landscape of diseases, heart failure with preserved ejection fraction (HFpEF) now encompasses more than half of all heart failure patients. This condition is clinically diverse, involving multiple organ systems and often occurring alongside the aging process.
Zhongwen Qi   +6 more
wiley   +1 more source

Assessing oxidative stress in foetuses with β-globin gene mutations. [PDF]

open access: yesIndian J Med Res
Nayak S   +5 more
europepmc   +1 more source

Benzochalcogenodiazoles, Synthesis, and Applications in Medicinal Chemistry and Photomedicine

open access: yesEuropean Journal of Organic Chemistry, Volume 28, Issue 23, June 23, 2025.
Benzochalcogenodiazoles (BXD) including benzoxadiazoles, benzothiadiazoles, and benzoselenadiazoles are initially mainly designed for optoelectronic materials as electron‐deficient cores. Nevertheless, they are now extending their application to biology.
Jean‐Elie Zheng   +2 more
wiley   +1 more source

Different Effects of Riociguat and Vericiguat on Pulmonary Vessels and Airways. [PDF]

open access: yesBiomedicines
Nubbemeyer K   +6 more
europepmc   +1 more source

Involvement of endothelins, peptides with potent vasoactive properties, in HIV-1 encephalopathy [PDF]

open access: yes, 1992
Bogner, Johannes R.   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy